TAILIEUCHUNG - Regulation of DMT1 on bone microstructure in type 2 diabetes

Diabetic osteoporosis is gradually attracted people's attention. However, the process of bone microstructure changes in diabetic patients, and the exact mechanism of osteoblast iron overload are unclear. | Int. J. Med. Sci. 2015 Vol. 12 441 IVYSPRING ĩtttonmtìnníií n-C OM ơrdrnf ĩriữnrữc INTERNATIONAL PUBLISHER international journal Oj jVLeaicai Sciences 2015 12 5 441-449. doi Research Paper Regulation of DMT1 on Bone Microstructure in Type 2 Diabetes Wei-Lin Zhangt Hong-Zheng Mengt Mao-Wei YangE Department of Orthopedics the First Hospital of China Medical University Shenyang Liaoning China t These authors contribute equally to this work. El Corresponding author Mao-Wei Yang Department of Orthopedics The First Hospital of China Medical University 155 North Nanjing Street Shenyang Liaoning 110001 China. E-mail ymw69@ FAX 86 24 83283360 Phone 86 24 83283360 2015 Ivyspring International Publisher. Reproduction is permitted for personal noncommercial use provided that the article is in whole unmodified and properly cited. See http terms for terms and conditions. Received Accepted Published Abstract Diabetic osteoporosis is gradually attracted people s attention. However the process of bone microstructure changes in diabetic patients and the exact mechanism of osteoblast iron overload are unclear. Therefore the present study aimed to explore the function of DMT1 in the pathological process of diabetic osteoporosis. We build the type two diabetes osteoporosis models with SD rats and Belgrade rats respectively. Difference expression of DMT1 was detected by using the method of immunohistochemistry and western blotting. Detection of bone microstructure and biomechanics and iron content for each group of samples. We found that DMT1 expression in type 2 diabetic rats was higher than that in normal rats. The bone biomechanical indices and bone microstructure in the rat model deficient in DMT1 was significantly better than that in the normal diabetic model. The loss of DMT1 can reduce the content of iron in bone. These findings indicate that DMT1 expression was enhanced in the bone tissue of type

• Y khoa - Dược
• Type 2 diabetes
• Micro CT
• Divalent metal ion transporter 1
• Bone mineral density
• Insulin sensitivity index
• Prevalence of type 2 diabetes
• Risk factors for type 2 diabetes
• Type 2 diabetes causes
• Associated factors of type 2 diabetes
• diabetes
• diabetes treatment
• diabetes prevention
• Oral Diabetes Medications
• Adults With Type 2 Diabetes
• Changing self care knowledge
• The outpatients with Type 2 diabetes
• Yenbai provincal hospital
• Type 2 diabetes for outpatient examination
• BMC Cancer
• Within class differences
• Patients with type 2 diabetes
• Cancer risk
• Weight gain
• Thiazolidinediones in type 2
• Type 2 diabetes mellitus
• TZDs exert weight gain
• Mechanism of TZDs on weight gain
• Diabetes mellitus patients
• Quality of life
• Life among out patients
• Type 2 diabetes managed
• QOL in this patient group
• Knowledge on the diet
• Practice on diet
• Outpatients with type 2 diabetes
• General information
• Drug use
• Agricultural Hospital
• Pre designed questionnaires
• Treatment of diabetes
• International Diabetes Federation
• Breast cancer
• Diabetes mellitus
• Female diabetes
• Cox regression
• Casein Kinase 2 Alpha 1
• Real time quantitative polymerase chain reactions
• Enzyme linked immunosorbent
• Protein complex
• Diabetes related protein complex
• Polyacrylamide gel electrophoresis
• Immunoinflammation related protein complexes
• Self care
• Self assessment questionnaires
• Diabetes self care
• Physical activity
• Risk factors
• Cancer development
• Diabetes duration
• Body mass index
• BMC Musculoskeletal Disorders
• Healthcare resource utilization
• Hospital claims database analysis
• Raloxifene hydrochloride
• Retrospective cohort study
• Prostate cancer diagnosis
• Gonadotropin releasing hormone agonists
• Prostate cancer
• BMC Geriatrics
• Myocardial infarction
• Impaired fasting glucose
• Glucose tolerance
• Laryngeal cancer
• C peptide
• Proliferative diabetic retinopathy
• Diabetic nephropathy
• Bariatric surgery
• Intensive insulin therapy
• Diabetes complications
• Glycemic control
• Retrospective study
• Dipeptidyl peptidase inhibitor
• Oral antidiabetic drug
• DPP 4 inhibitors
• Type 2 diabetes inadequately
• BMC Pediatrics
• Extract of Gingko biloba
• High fat diet
• Pancreatic β cells
• BMC Pharmacology and Toxicology
• Remogliflozin etabonate
• Sodium dependent glucose transporter 2 inhibitor
• Lower plasma glucose
• Tạp chí khoa học
• Tạp chí y dược
• Y dược quân sự
• Diet pattern
• Plasma leptin level